23 results
424B4
CGTX
Cognition Therapeutics Inc
14 Nov 22
Prospectus supplement with pricing info
6:02am
penalties;
the product may become less competitive; and
our reputation may suffer.
Any of these events could prevent us from achieving or maintaining … candidates;
injury to our reputation;
withdrawal of clinical trial participants;
costs to defend the related litigation;
diversion of management’s
DRS
CGTX
Cognition Therapeutics Inc
20 Oct 22
Draft registration statement
12:00am
less competitive; and
our reputation may suffer.
Any of these events could prevent us from achieving or maintaining market acceptance of the particular … ;
injury to our reputation;
withdrawal of clinical trial participants;
costs to defend the related litigation;
diversion of management’s time
10-K
2021 FY
CGTX
Cognition Therapeutics Inc
30 Mar 22
Annual report
7:40am
of criminal penalties;
the product may become less competitive; and
our reputation may suffer.
Any of these events could prevent us from achieving … reputation;
withdrawal of clinical trial participants;
costs to defend the related litigation;
diversion of management’s time and our resources
10-Q
irlnr71kmmtqfwlrun
17 Nov 21
Quarterly report
5:15pm
424B4
oc7zrl d5
12 Oct 21
Prospectus supplement with pricing info
4:11pm
S-1
EX-10.18
1oboiqakl3sr
19 Jul 21
IPO registration
7:02am
S-1
EX-10.6
tw9hzz3z
19 Jul 21
IPO registration
7:02am
S-1
EX-10.15
ggqg9e70vhdkk
19 Jul 21
IPO registration
7:02am
S-1
EX-10.17
c4vzhrl
19 Jul 21
IPO registration
7:02am
S-1
fmliwszu7zis5j oq
19 Jul 21
IPO registration
7:02am
S-1
EX-10.19
yz5laur8o4sw90jlilo
19 Jul 21
IPO registration
7:02am
DRS/A
k224mrgn1
23 Jun 21
Draft registration statement (amended)
12:00am
DRS
EX-10.14
s5od4uhm1w12sfvx
7 May 21
Draft registration statement
12:00am
DRS
EX-10.16
kvj444fu
7 May 21
Draft registration statement
12:00am